Patents by Inventor David Platts

David Platts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020102601
    Abstract: The present invention relates to a blood cell proliferation assay employing Staphylococcus aureus antigen capable of inducing a proliferative response. The assay finds particular application in testing cattle, including cows and bulls for use in predicting resistance to subclinical or clinical mastitis.
    Type: Application
    Filed: March 27, 2002
    Publication date: August 1, 2002
    Inventors: Julie Lydia Fitzpatrick, Michael James Stear, David Platt, Karen Logan
  • Patent number: 6423314
    Abstract: The active, galactose binding site of proteins associated with metastatic tumor cells has been identified and sequenced. The polypeptide comprising the active site may be used as an immunotherapeutic agent. Identification of the site makes possible an in vivo diagnostic assay for metastatic cell as well as therapeutic methodologies and materials.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: July 23, 2002
    Inventor: David Platt
  • Publication number: 20020091966
    Abstract: A self-test electronic assembly performs self-testing, such as diagnostic or run-in testing of components and circuits, based upon internally stored test procedures. The results of self-testing are stored internally to the device, providing valuable information regarding the self-test electronic assembly, both during the manufacturing process, and preferably for ongoing in-situ operation. A test system is preferably linked to one or more self-test electronic assemblies, and provides loopback circuitry for each installed self-test electronic assembly, whereby the self-test electronic assemblies can further test components, circuitry, and security encoding and decoding operation. The preferred test rack also provides efficient and consistent monitoring and quality control over the self-testing of self-test electronic assemblies.
    Type: Application
    Filed: March 14, 2002
    Publication date: July 11, 2002
    Inventors: James M. Barton, Shahin Tahmassebi, David Platt
  • Publication number: 20020068077
    Abstract: A pharmaceutical compound and a process for making the compound is provided where the compound includes a therapeutic agent, a spacer and a galactose, the spacer being covalently linked to the therapeutic agent at a first site on the spacer and covalently linked to the galactose by an ether bond at a second site on the spacer to form a conjugate. The conjugate may be used to treat a subject suffering from a medical condition, so as to reduce the side effects associated with the therapeutic agent by administering an effective dose of the conjugate to the subject so that the side effects in the subject are less then they would have been with the unconjugated therapeutic agent.
    Type: Application
    Filed: September 24, 2001
    Publication date: June 6, 2002
    Inventors: Anatole Klyosov, David Platt
  • Patent number: 6385739
    Abstract: A self-test electronic assembly performs self-testing, such as diagnostic or run-in testing of components and circuits, based upon internally stored test procedures. The results of self-testing are stored internally to the device, providing valuable information regarding the self-test electronic assembly, both during the manufacturing process, and preferably for ongoing in-situ operation. A test system is preferably linked to one or more self-test electronic assemblies, and provides loopback circuitry for each installed self-test electronic assembly, whereby the self-test electronic assemblies can further test components, circuitry, and security encoding and decoding operation. The preferred test rack also provides efficient and consistent monitoring and quality control over the self-testing of self-test electronic assemblies.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: May 7, 2002
    Assignee: Tivo Inc.
    Inventors: James M. Barton, Shahin Tahmassebi, David Platt
  • Publication number: 20010010817
    Abstract: The active, galactose binding site of proteins associated with metastatic tumor cells has been identified and sequenced. The polypeptide comprising the active site may be used as an immunotherapeutic agent. Identification of the site makes possible an in vivo diagnostic assay for metastatic cells as well as therapeutic methodologies and materials.
    Type: Application
    Filed: December 28, 2000
    Publication date: August 2, 2001
    Inventor: David Platt
  • Patent number: 6245316
    Abstract: A radioimaging material or a radioprotective material is attached to a carbohydrate which is capable of binding to or penetrating a cell. The carbohydrate material can be preferentially taken up by tumor cells and provides for imaging thereof.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: June 12, 2001
    Inventor: David Platt
  • Patent number: 6234635
    Abstract: The present invention includes maintaining the region of the proximal lens of a laparoscope at greater than ambient temperature in order to prevent fogging during use. Heating is accomplished using commercially available chemical heat packs generally used for heating boots or gloves. The invention differs from other anti-fogging devices, which either immerse the distal lens region of the laparoscope in a warm fluid or treat this lens with anti-fogging solutions, in that above-ambient temperature is continuously maintained throughout the laparoscope, since it is known that a cool laparoscope fogs when placed in the vicinity of warm, wet tissue.
    Type: Grant
    Filed: July 30, 1998
    Date of Patent: May 22, 2001
    Inventors: Michael R. Seitzinger, David Platts
  • Patent number: 5965545
    Abstract: Materials comprised of linked, repeat units of beta glucosamine, having a molecular weight in the range of 400 to 10,000 are highly effective in controlling fungus infestation in agricultural crops, both pre-harvest and post-harvest. The antifungal material is preferably combined with a mildly acidic solvent to produce a composition having a slightly acidic, or near neutral pH. When the antifungal material is combined with a chitosan matrix, a synergistic interaction occurs which greatly enhances the effect of the resultant composition. Also disclosed is a method for producing a chitin or chitosan based material which will dissolve in water having a neutral pH.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: October 12, 1999
    Assignee: State of Israel, Ministry of Agriculture, Agricultural Research Organization, The Volcani Center
    Inventors: Noach Ben-Shalom, David Platt
  • Patent number: 5891861
    Abstract: An oligomer comprised of repeat units of beta glucosamine exhibits broad antifungal activity. The oligomer preferably has a molecular weight in the range of 4,000-18,000 dalton, and may be partially acetylated. These materials are highly effective against a variety of fungi including various species of Candida.
    Type: Grant
    Filed: October 15, 1996
    Date of Patent: April 6, 1999
    Inventor: David Platt
  • Patent number: 5759992
    Abstract: An immunotherapeutic agent is prepared from cells of E. coli or members of the genus Mycobacterium. The material is effective as an anti-tumor agent, an immunostimulant, and an adjuvant. Also disclosed is a method of evoking an immunostimulatory response through the activation of the RAS gene.
    Type: Grant
    Filed: March 7, 1996
    Date of Patent: June 2, 1998
    Assignee: David Platt
    Inventor: David Platt
  • Patent number: 5681923
    Abstract: The active, galactose binding site of proteins associated with metastatic tumor cells has been identified and sequenced (SEQ. ID. NO:1). The polypeptide comprising the active site may be used as an immunotherapeutic agent. Identification of the site makes possible an in vivo diagnostic assay for metastatic cells as well as therapeutic methodologies and materials.
    Type: Grant
    Filed: October 6, 1995
    Date of Patent: October 28, 1997
    Inventor: David Platt
  • Patent number: 5527770
    Abstract: An immunotherapeutic agent is prepared from cells of E. coli or members of the genus Mycobacterium. The material is effective as an anti-tumor agent, an immunostimulant, and an adjuvant. Also disclosed is a method of evoking an immunostimulatory response through the activation of the RAS gene.
    Type: Grant
    Filed: August 31, 1994
    Date of Patent: June 18, 1996
    Assignee: International Gene Group, Inc.
    Inventor: David Platt
  • Patent number: 5481804
    Abstract: A lightweight, slender knife having a replaceable, retractable cutting blade, which may be locked either in the operating or deployed position, or in a retracted or safety position, by using a single digit on one hand, is described. Safety of hospital personnel and medical waste-disposal personnel is achieved in the surgical scalpel embodiment of the present knife without loss of function or convenience of the scalpel. An automatically retracting embodiment of the knife is also described.
    Type: Grant
    Filed: October 12, 1994
    Date of Patent: January 9, 1996
    Inventor: David Platts
  • Patent number: 5475925
    Abstract: A three-piece knife having a replacable, retractable cutting blade, which may be locked either in the operating or deployed position, or in a retracted or safety position, by using a single digit on one hand, is described. Safety of hospital personnel and medical waste-disposal personnel is achieved in the surgical scalpel embodiment of the three-piece knife without loss of function or convenience of the scalpel.
    Type: Grant
    Filed: March 21, 1994
    Date of Patent: December 19, 1995
    Inventors: Philip H. Newman, B. Michael Jackson, Charles T. Gregg, David Platts
  • Patent number: 5403337
    Abstract: A surgical scalpel having a replacable, retractable cutting blade which may be locked in the operating or deployed position using a single digit on one hand is described. Safety of hospital personnel and medical waste disposal personnel is achieved without loss of function or convenience of the scalpel.
    Type: Grant
    Filed: July 5, 1994
    Date of Patent: April 4, 1995
    Inventor: David Platts
  • Patent number: 5201748
    Abstract: A surgical scalpel having a replacable, retractable cutting blade which may be locked in the operating or deployed position using a single digit on one hand is described. Safety of hospital personnel and medical waste disposal personnel is achieved without loss of function or convenience of the scalpel.
    Type: Grant
    Filed: June 1, 1992
    Date of Patent: April 13, 1993
    Inventors: Philip H. Newman, B. Michael Jackson, Charles T. Gregg, David Platts
  • Patent number: 4937108
    Abstract: A carrier device for releasably holding a strip of material adapted for utilization and manufacture of semiconductor devices including first and second frame members interconnected by hinge means which permits both pivotal and linear movement of the frame members relative to one another.
    Type: Grant
    Filed: November 4, 1988
    Date of Patent: June 26, 1990
    Assignee: Camtex Horizons, Inc.
    Inventors: Rod Crisp, Roger Tregear, David Platt